Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Ponti

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Alimentary Pharmacology & Therapeutics|February 12, 2004
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokineticsM Tonini, L Cipollina, E Poluzzi, et al.
Pharmacology|January 1, 1989
Inhibitory effects of DF 594, a new antispasmodic agent, on intestinal motility in the dogF De Ponti, L Ambrosoli, M Borsa, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1985
Subsensitivity of enteric cholinergic neurones to alpha 2-adrenoceptor agonists after chronic sympathetic denervationM Marcoli, S Lecchini, F De Ponti, et al.
Pharmacological Research|September 1, 1990
Importance of cholinergic pathways in the regulation of colonic motility in the rabbitF De Ponti, M Cosentino, L D'Angelo, et al.
Neurogastroenterology and Motility|March 21, 2002
Intestinal motor stimulation by the 5-HT4 receptor agonist ML10302: differential involvement of tachykininergic pathways in the canine small bowel and colonF De Ponti, F Crema, E Moro, et al.
Thrombosis Research|June 15, 1991
Intraduodenal absorption of the new UF-heparin salt ITF 1057 in the conscious dogI Caramazza, G D'Atri, M L Bossi, et al.
Pharmacological Research|November 1, 1989
Regulation of intestinal motility by different muscarinic receptor subtypesF de Ponti, L Ambrosoli, L D'Angelo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 13, 2016
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting SystemE Raschi, E Poluzzi, A Koci, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1989
Effect of beta-casomorphins on intestinal propulsion in the guinea-pig colonF De Ponti, M Marcoli, S Lecchini, et al.
Drug Safety|March 1, 1993
Immunological adverse effects of anticonvulsants. What is their clinical relevance?F De Ponti, S Lecchini, M Cosentino, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|February 12, 2004
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokineticsM Tonini, L Cipollina, E Poluzzi, et al.
Pharmacology|January 1, 1989
Inhibitory effects of DF 594, a new antispasmodic agent, on intestinal motility in the dogF De Ponti, L Ambrosoli, M Borsa, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1985
Subsensitivity of enteric cholinergic neurones to alpha 2-adrenoceptor agonists after chronic sympathetic denervationM Marcoli, S Lecchini, F De Ponti, et al.
Pharmacological Research|September 1, 1990
Importance of cholinergic pathways in the regulation of colonic motility in the rabbitF De Ponti, M Cosentino, L D'Angelo, et al.
Neurogastroenterology and Motility|March 21, 2002
Intestinal motor stimulation by the 5-HT4 receptor agonist ML10302: differential involvement of tachykininergic pathways in the canine small bowel and colonF De Ponti, F Crema, E Moro, et al.
Thrombosis Research|June 15, 1991
Intraduodenal absorption of the new UF-heparin salt ITF 1057 in the conscious dogI Caramazza, G D'Atri, M L Bossi, et al.
Pharmacological Research|November 1, 1989
Regulation of intestinal motility by different muscarinic receptor subtypesF de Ponti, L Ambrosoli, L D'Angelo, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 13, 2016
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting SystemE Raschi, E Poluzzi, A Koci, et al.
The Journal of Pharmacy and Pharmacology|May 1, 1989
Effect of beta-casomorphins on intestinal propulsion in the guinea-pig colonF De Ponti, M Marcoli, S Lecchini, et al.
Drug Safety|March 1, 1993
Immunological adverse effects of anticonvulsants. What is their clinical relevance?F De Ponti, S Lecchini, M Cosentino, et al.
Pageof 12